Franzen Samuel R P, Chandler Clare, Siribaddana Sisira, Atashili Julius, Angus Brian, Lang Trudie
The Global Health Network, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Oxford Policy Management, Oxford, UK.
BMJ Open. 2017 Oct 13;7(10):e017246. doi: 10.1136/bmjopen-2017-017246.
In 2013, the WHO stated that unless low-income and middle-income countries (LMICs) become producers of research, health goals would be hard to achieve. Among the capacities required to build a local evidence base, ability to conduct clinical trials is important. There is no evidence-based guidance for the best ways to develop locally led trial capacity. This research aims to identify the barriers and enablers to locally led clinical trial conduct in LMICs and determine strategies for their sustainable development.
Prospective, multiple case study design consisting of interviews (n=34), focus group discussions (n=13) and process mapping exercises (n=10).
Case studies took place in Ethiopia (2011), Cameroon (2012) and Sri Lanka (2013).
Local health researchers with previous experiences of clinical trials or stakeholders with an interest in trials were purposively selected through registration searches and snowball sampling (n=100).
Discussion notes and transcripts were analysed using thematic coding analysis. Key themes and mechanisms were identified.
Institutions and individuals were variably successful at conducting trials, but there were strong commonalities in the barriers and enablers across all levels and functions of the research systems. Transferable mechanisms were summarised into the necessary conditions for trial undertaking, which included: awareness of research, motivation, knowledge and technical skills, leadership capabilities, forming collaborations, inclusive trial operations, policy relevance and uptake and macro and institutional strengthening.
Barriers and enablers to locally led trial undertaking exist at all levels and functions of LMIC research systems. Establishing the necessary conditions to facilitate this research will require multiple, coordinated interventions that seek to resolve them in a systemic manner. The strategies presented in the discussion provide an evidence-based framework for a self-sustaining capacity development approach. This represents an important contribution to the literature that will be relevant for research funders, users and producers.
2013年,世界卫生组织指出,除非低收入和中等收入国家(LMICs)成为研究的生产者,否则卫生目标将难以实现。在建立本地证据基础所需的能力中,进行临床试验的能力很重要。对于发展本地主导的试验能力的最佳方法,尚无循证指南。本研究旨在确定低收入和中等收入国家本地主导的临床试验开展的障碍和促进因素,并确定其可持续发展的策略。
前瞻性多案例研究设计,包括访谈(n = 34)、焦点小组讨论(n = 13)和流程映射练习(n = 10)。
案例研究分别在埃塞俄比亚(2011年)、喀麦隆(2012年)和斯里兰卡(2013年)进行。
通过注册搜索和滚雪球抽样,有目的地选择了有临床试验经验的本地卫生研究人员或对试验感兴趣的利益相关者(n = 100)。
使用主题编码分析对讨论笔记和文字记录进行分析。确定关键主题和机制。
各机构和个人在进行试验方面的成功程度各不相同,但研究系统的所有层面和职能在障碍和促进因素方面有很强的共性。可转移机制被总结为试验开展的必要条件,包括:研究意识、动机、知识和技术技能、领导能力、建立合作关系、包容性试验操作、政策相关性及采纳以及宏观和机构强化。
低收入和中等收入国家研究系统的所有层面和职能都存在本地主导试验开展的障碍和促进因素。建立促进这项研究的必要条件需要采取多种协调一致的干预措施,以系统的方式解决这些问题。讨论中提出的策略为自我维持的能力发展方法提供了一个循证框架。这对文献做出了重要贡献,将对研究资助者、使用者和生产者具有参考价值。